Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imaging

Changes in expression and dysfunctional signaling of TrkA/B/C receptors and oncogenic Trk fusion proteins are found in neurological diseases and cancers. Here, we describe the development of a first 18F-labeled optimized lead suitable for in vivo imaging of Trk, [18F]TRACK, which is radiosynthesized...

Full description

Saved in:
Bibliographic Details
Main Authors: Bernard-Gauthier, Vadim (Author) , Mahringer, Anne (Author) , Wängler, Björn (Author) , Wängler, Carmen (Author) , Fricker, Gert (Author)
Format: Article (Journal)
Language:English
Published: 2018
In: Journal of medicinal chemistry
Year: 2017, Volume: 61, Issue: 4, Pages: 1737-1743
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.7b01607
Online Access:Verlag, Volltext: https://doi.org/10.1021/acs.jmedchem.7b01607
Get full text
Author Notes:Vadim Bernard-Gauthier, Andrew V. Mossine, Anne Mahringer, Arturo Aliaga, Justin J. Bailey, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Marilyn Grand’Maison, Pierre-Luc Rochon, Björn Wängler, Carmen Wängler, Peter Bartenstein, Alexey Kostikov, David R. Kaplan, Gert Fricker, Pedro Rosa-Neto, Peter J. H. Scott, and Ralf Schirrmacher

MARC

LEADER 00000caa a2200000 c 4500
001 1669957128
003 DE-627
005 20220816195509.0
007 cr uuu---uuuuu
008 190724r20182017xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.jmedchem.7b01607  |2 doi 
035 |a (DE-627)1669957128 
035 |a (DE-599)KXP1669957128 
035 |a (OCoLC)1341234111 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bernard-Gauthier, Vadim  |e VerfasserIn  |0 (DE-588)1159777292  |0 (DE-627)1022455362  |0 (DE-576)42821732X  |4 aut 
245 1 0 |a Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imaging  |c Vadim Bernard-Gauthier, Andrew V. Mossine, Anne Mahringer, Arturo Aliaga, Justin J. Bailey, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Marilyn Grand’Maison, Pierre-Luc Rochon, Björn Wängler, Carmen Wängler, Peter Bartenstein, Alexey Kostikov, David R. Kaplan, Gert Fricker, Pedro Rosa-Neto, Peter J. H. Scott, and Ralf Schirrmacher 
246 3 3 |a [18 F] Track 
264 1 |c 2018 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 24.07.2019 
500 |a Published: December 19, 2017 
500 |a Im Titel ist die 18 in [18F]TRACK hochgestellt 
520 |a Changes in expression and dysfunctional signaling of TrkA/B/C receptors and oncogenic Trk fusion proteins are found in neurological diseases and cancers. Here, we describe the development of a first 18F-labeled optimized lead suitable for in vivo imaging of Trk, [18F]TRACK, which is radiosynthesized with ease from a nonactivated aryl precursor concurrently combining largely reduced P-gp liability and improved brain kinetics compared to previous leads while displaying high on-target affinity and human kinome selectivity. 
534 |c 2017 
700 1 |a Mahringer, Anne  |e VerfasserIn  |0 (DE-588)143168827  |0 (DE-627)704409607  |0 (DE-576)335452981  |4 aut 
700 1 |a Wängler, Björn  |d 1975-  |e VerfasserIn  |0 (DE-588)129702218  |0 (DE-627)477593909  |0 (DE-576)297793888  |4 aut 
700 1 |a Wängler, Carmen  |d 1978-  |e VerfasserIn  |0 (DE-588)133775593  |0 (DE-627)556368177  |0 (DE-576)30009230X  |4 aut 
700 1 |a Fricker, Gert  |d 1956-  |e VerfasserIn  |0 (DE-588)1042227675  |0 (DE-627)768469465  |0 (DE-576)393783464  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medicinal chemistry  |d Washington, DC : ACS, 1959  |g 61(2018), 4, Seite 1737-1743  |h Online-Ressource  |w (DE-627)302468846  |w (DE-600)1491411-6  |w (DE-576)090855132  |x 1520-4804  |7 nnas  |a Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imaging 
773 1 8 |g volume:61  |g year:2018  |g number:4  |g pages:1737-1743  |g extent:7  |a Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imaging 
856 4 0 |u https://doi.org/10.1021/acs.jmedchem.7b01607  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190724 
993 |a Article 
994 |a 2018 
998 |g 1042227675  |a Fricker, Gert  |m 1042227675:Fricker, Gert  |d 160000  |d 160100  |e 160000PF1042227675  |e 160100PF1042227675  |k 0/160000/  |k 1/160000/160100/  |p 17 
998 |g 133775593  |a Wängler, Carmen  |m 133775593:Wängler, Carmen  |d 60000  |d 62900  |e 60000PW133775593  |e 62900PW133775593  |k 0/60000/  |k 1/60000/62900/  |p 13 
998 |g 129702218  |a Wängler, Björn  |m 129702218:Wängler, Björn  |d 60000  |d 62900  |e 60000PW129702218  |e 62900PW129702218  |k 0/60000/  |k 1/60000/62900/  |p 12 
998 |g 143168827  |a Mahringer, Anne  |m 143168827:Mahringer, Anne  |d 160000  |d 160100  |e 160000PM143168827  |e 160100PM143168827  |k 0/160000/  |k 1/160000/160100/  |p 3 
999 |a KXP-PPN1669957128  |e 3496562889 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Vadim","role":"aut","display":"Bernard-Gauthier, Vadim","family":"Bernard-Gauthier"},{"given":"Anne","role":"aut","display":"Mahringer, Anne","family":"Mahringer"},{"display":"Wängler, Björn","given":"Björn","role":"aut","family":"Wängler"},{"display":"Wängler, Carmen","given":"Carmen","role":"aut","family":"Wängler"},{"role":"aut","given":"Gert","display":"Fricker, Gert","family":"Fricker"}],"name":{"displayForm":["Vadim Bernard-Gauthier, Andrew V. Mossine, Anne Mahringer, Arturo Aliaga, Justin J. Bailey, Xia Shao, Jenelle Stauff, Janna Arteaga, Phillip Sherman, Marilyn Grand’Maison, Pierre-Luc Rochon, Björn Wängler, Carmen Wängler, Peter Bartenstein, Alexey Kostikov, David R. Kaplan, Gert Fricker, Pedro Rosa-Neto, Peter J. H. Scott, and Ralf Schirrmacher"]},"id":{"doi":["10.1021/acs.jmedchem.7b01607"],"eki":["1669957128"]},"physDesc":[{"extent":"7 S."}],"note":["Gesehen am 24.07.2019","Published: December 19, 2017","Im Titel ist die 18 in [18F]TRACK hochgestellt"],"relHost":[{"pubHistory":["1.1959 -"],"title":[{"title":"Journal of medicinal chemistry","title_sort":"Journal of medicinal chemistry"}],"part":{"year":"2018","text":"61(2018), 4, Seite 1737-1743","volume":"61","issue":"4","pages":"1737-1743","extent":"7"},"language":["eng"],"origin":[{"publisher":"ACS ; ACS","dateIssuedDisp":"1959-","dateIssuedKey":"1959","publisherPlace":"Washington, DC ; Easton, Pa."}],"recId":"302468846","type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["302468846"],"issn":["1520-4804"],"zdb":["1491411-6"]},"disp":"Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imagingJournal of medicinal chemistry","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 02.10.2020"],"name":{"displayForm":["American Chemical Society"]}}],"recId":"1669957128","origin":[{"dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"titleAlt":[{"title":"[18 F] Track"}],"title":[{"title_sort":"Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imaging","title":"Identification of [18F]TRACK, a fluorine-18-labeled tropomyosin receptor kinase (Trk) inhibitor for PET imaging"}],"language":["eng"]} 
SRT |a BERNARDGAUIDENTIFICA2018